These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18363541)

  • 1. Drug-induced phototoxicity evoked by inhibition of human ABC transporter ABCG2: development of in vitro high-speed screening systems.
    Tamura A; An R; Hagiya Y; Hoshijima K; Yoshida T; Mikuriya K; Ishikawa T
    Expert Opin Drug Metab Toxicol; 2008 Mar; 4(3):255-72. PubMed ID: 18363541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs.
    Tamura A; Onishi Y; An R; Koshiba S; Wakabayashi K; Hoshijima K; Priebe W; Yoshida T; Kometani S; Matsubara T; Mikuriya K; Ishikawa T
    Drug Metab Pharmacokinet; 2007 Dec; 22(6):428-40. PubMed ID: 18159130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular phototoxicity evoked through the inhibition of human ABC transporter ABCG2 by cyclin-dependent kinase inhibitors in vitro.
    An R; Hagiya Y; Tamura A; Li S; Saito H; Tokushima D; Ishikawa T
    Pharm Res; 2009 Feb; 26(2):449-58. PubMed ID: 18841444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine kinase inhibitors enhance ciprofloxacin-induced phototoxicity by inhibiting ABCG2.
    Mealey KL; Dassanayake S; Burke NS
    Oncology; 2014; 87(6):364-70. PubMed ID: 25227759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ABCG2 and ABCB6 in porphyrin metabolism and cell survival.
    Krishnamurthy P; Schuetz JD
    Curr Pharm Biotechnol; 2011 Apr; 12(4):647-55. PubMed ID: 21118089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro.
    Houghton PJ; Germain GS; Harwood FC; Schuetz JD; Stewart CF; Buchdunger E; Traxler P
    Cancer Res; 2004 Apr; 64(7):2333-7. PubMed ID: 15059881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porphyrin accumulation in humans with common dysfunctional variants of ABCG2, a porphyrin transporter: potential association with acquired photosensitivity.
    Sakiyama M; Matsuo H; Toyoda Y; Yonekura Y; Ishikawa T; Nakayama A; Higashino T; Kawamura Y; Fujimoto N; Shinomiya N; Satoh T
    Hum Cell; 2021 Jul; 34(4):1082-1086. PubMed ID: 34009629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.
    Shukla S; Robey RW; Bates SE; Ambudkar SV
    Drug Metab Dispos; 2009 Feb; 37(2):359-65. PubMed ID: 18971320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapy.
    Robey RW; Steadman K; Polgar O; Bates SE
    Cancer Biol Ther; 2005 Feb; 4(2):187-94. PubMed ID: 15684613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2.
    Liu W; Baer MR; Bowman MJ; Pera P; Zheng X; Morgan J; Pandey RA; Oseroff AR
    Clin Cancer Res; 2007 Apr; 13(8):2463-70. PubMed ID: 17438106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: identification of alleles that are defective in porphyrin transport.
    Tamura A; Watanabe M; Saito H; Nakagawa H; Kamachi T; Okura I; Ishikawa T
    Mol Pharmacol; 2006 Jul; 70(1):287-96. PubMed ID: 16608919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of genotypes and haplotypes of multi-drug transporter genes ABCB1 and ABCG2 with clinical response to imatinib mesylate in chronic myeloid leukemia patients.
    Au A; Aziz Baba A; Goh AS; Wahid Fadilah SA; Teh A; Rosline H; Ankathil R
    Biomed Pharmacother; 2014 Apr; 68(3):343-9. PubMed ID: 24581936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.
    Jonker JW; Buitelaar M; Wagenaar E; Van Der Valk MA; Scheffer GL; Scheper RJ; Plosch T; Kuipers F; Elferink RP; Rosing H; Beijnen JH; Schinkel AH
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15649-54. PubMed ID: 12429862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib sensitizes imatinib-resistant K562 cells to imatinib by inhibiting MRP1-5, ABCA2 and ABCG2 transporters via Wnt and Ras signaling pathways.
    Dharmapuri G; Doneti R; Philip GH; Kalle AM
    Leuk Res; 2015 Jul; 39(7):696-701. PubMed ID: 25916699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human ABC transporter ABCG2 in xenobiotic protection and redox biology.
    Wakabayashi K; Tamura A; Saito H; Onishi Y; Ishikawa T
    Drug Metab Rev; 2006; 38(3):371-91. PubMed ID: 16877258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic resistance to imatinib mesylate: role of the ABC drug pumps ABCG2 (BCRP) and ABCB1 (MDR1) in the oral bioavailability of imatinib.
    Burger H; Nooter K
    Cell Cycle; 2004 Dec; 3(12):1502-5. PubMed ID: 15611623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins inhibit ABCB1 and ABCG2 drug transporter activity in chronic myeloid leukemia cells and potentiate antileukemic effects of imatinib.
    Glodkowska-Mrowka E; Mrowka P; Basak GW; Niesiobedzka-Krezel J; Seferynska I; Wlodarski PK; Jakobisiak M; Stoklosa T
    Exp Hematol; 2014 Jun; 42(6):439-47. PubMed ID: 24667683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human ABC transporter ABCG2 in cancer chemotherapy and pharmacogenomics.
    Ishikawa T; Nakagawa H
    J Exp Ther Oncol; 2009; 8(1):5-24. PubMed ID: 19827267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
    Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A
    Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.